Total Sales of 25 Japan Drug Makers Up 12.9% in 1st Half, Global Players Fare Well While SMEs Falter

Combined sales of 25 key domestic pharmaceutical companies climbed 12.9% year-on-year in the first half of FY2022, with double-digit growth by major drug makers more than offsetting the sluggish results of smaller companies. The Jiho tally covered members of the...read more